|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spiro SG and Silvestri GA: One hundred
years of lung cancer. Am J Respir Crit Care Med. 172:523–529. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Radzikowska E, Głaz P and Roszkowski K:
Lung cancer in women: Age, smoking, histology, performance status,
stage, initial treatment and survival. Population-based study of 20
561 cases. Ann Oncol. 13:1087–1093. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murphy PM, Baggiolini M, Charo IF, Hébert
CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ and Power CA:
International union of pharmacology. XXII. Nomenclature for
chemokine receptors. Pharmacol Rev. 52:145–176. 2000.PubMed/NCBI
|
|
5
|
Mantovani A, Allavena P, Sozzani S, Vecchi
A, Locati M and Sica A: Chemokines in the recruitment and shaping
of the leukocyte infiltrate of tumors. Semin Cancer Biol.
14:155–160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantovani A: Chemokines in neoplastic
progression. Semin Cancer Biol. 14:147–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beider K, Abraham M, Begin M, Wald H,
Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E, et
al: Interaction between CXCR4 and CCL20 pathways regulates tumor
growth. PLoS One. 4:e51252009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schutyser E, Struyf S and Van Damme J: The
CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor
Rev. 14:409–426. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bracke KR, Demedts IK, Joos GF and
Brusselle GG: CC-chemokine receptors in chronic obstructive
pulmonary disease. Inflamm Allergy Drug Targets. 6:75–79. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Demedts IK, Bracke KR, Van Pottelberge G,
Testelmans D, Verleden GM, Vermassen FE, Joos GF and Brusselle GG:
Accumulation of dendritic cells and increased CCL20 levels in the
airways of patients with chronic obstructive pulmonary disease. Am
J Respir Crit Care Med. 175:998–1005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghadjar P, Rubie C, Aebersold DM and
Keilholz U: The chemokine CCL20 and its receptor CCR6 in human
malignancy with focus on colorectal cancer. Int J Cancer.
125:741–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang YC, Hsiao YC, Chen YJ, Wei YY, Lai
TH and Tang CH: Stromal cell-derived factor-1 enhances motility and
integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent
pathway in human lung cancer cells. Biochem Pharmacol.
74:1702–1712. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ganju RK, Brubaker SA, Meyer J, Dutt P,
Yang Y, Qin S, Newman W and Groopman JE: The alpha-chemokine,
stromal cell-derived factor-1alpha, binds to the transmembrane
G-protein-coupled CXCR-4 receptor and activates multiple signal
transduction pathways. J Biol Chem. 273:23169–23175. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barbero S, Bonavia R, Bajetto A, Porcile
C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T and
Schettini G: Stromal cell-derived factor 1alpha stimulates human
glioblastoma cell growth through the activation of both
extracellular signal-regulated kinases 1/2 and Akt. Cancer Res.
63:1969–1974. 2003.PubMed/NCBI
|
|
16
|
Brand S, Olszak T, Beigel F, Diebold J,
Otte JM, Eichhorst ST, Göke B and Dambacher J: Cell differentiation
dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt
signaling resulting in proliferation and migration of colorectal
cancer cells. J Cell Biochem. 97:709–723. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee W, Jiang Z, Liu J, Haverty PM, Guan Y,
Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, et al: The mutation
spectrum revealed by paired genome sequences from a lung cancer
patient. Nature. 465:473–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mountain CF: Revisions in the
International System for staging lung cancer. Chest. 111:1710–1717.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Dleta C(T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang JM, Deng X, Gong W and Su S:
Chemokines and their role in tumor growth and metastasis. J Immunol
Methods. 220:1–17. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vicari AP and Caux C: Chemokines in
cancer. Cytokine Growth Factor Rev. 13:143–154. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kleeff J, Kusama T, Rossi DL, Ishiwata T,
Maruyama H, Friess H, Büchler MW, Zlotnik A and Korc M: Detection
and localization of MIP-3alpha/LARC/Exodus, a macrophage
proinflammatory chemokine, and its CCR6 receptor in human
pancreatic cancer. Int J Cancer. 81:650–657. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bell D, Chomarat P, Broyles D, Netto G,
Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA and
Banchereau J: In breast carcinoma tissue, immature dendritic cells
reside within the tumor, whereas mature dendritic cells are located
in peritumoral areas. J Exp Med. 190:1417–1426. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimizu Y, Murata H, Kashii Y, Hirano K,
Kunitani H, Higuchi K and Watanabe A: CC-chemokine receptor 6 and
its ligand macrophage inflammatory protein 3alpha might be involved
in the amplification of local necroinflammatory response in the
liver. Hepatology. 34:311–319. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kimsey TF, Campbell AS, Albo D, Wilson M
and Wang TN: Co-localization of macrophage inflammatory
protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes
pancreatic cancer cell invasion. Cancer J. 10:374–380. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghadjar P, Coupland SE, Na IK, Noutsias M,
Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C and
Keilholz U: Chemokine receptor CCR6 expression level and liver
metastasis in colorectal cancer. J Clin Oncol. 24:1910–1916. 2006.
View Article : Google Scholar : PubMed/NCBI
|
